A recent study showed that miR-26a is downregulated in hepatocellular carcinoma tissues and that this downregulation is an independent predictor of survival. Interestingly, the same study also reported that miR-26a downregulation causes a concomitant elevation of IL-6 expression. Because miR-26a exp...

Full description

Bibliographic Details
Main Authors: Yafei Zhang, Bicheng Zhang, Anran Zhang, Xiaohua Li, Jian Liu, Jie Zhao, Yong Zhao, Jianfei Gao, Dianchun Fang, Zhiguo Rao
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2013-01-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000100032
_version_ 1818982948703043584
author Yafei Zhang
Bicheng Zhang
Anran Zhang
Xiaohua Li
Jian Liu
Jie Zhao
Yong Zhao
Jianfei Gao
Dianchun Fang
Zhiguo Rao
author_facet Yafei Zhang
Bicheng Zhang
Anran Zhang
Xiaohua Li
Jian Liu
Jie Zhao
Yong Zhao
Jianfei Gao
Dianchun Fang
Zhiguo Rao
author_sort Yafei Zhang
collection DOAJ
description A recent study showed that miR-26a is downregulated in hepatocellular carcinoma tissues and that this downregulation is an independent predictor of survival. Interestingly, the same study also reported that miR-26a downregulation causes a concomitant elevation of IL-6 expression. Because miR-26a expression was found to be transcriptionally downregulated by oncogene c-Myc in various cancers, and the expression of c-Myc was increased by IL-6 stimulation, we hypothesized that IL-6 contributes to reduction of miR-26a in hepatocellular carcinoma. Serum IL-6 was measured by ELISA and miR-26a was detected by qRT-PCR. The data of 30 patients with hepatocellular carcinoma who had undergone surgical tumor resection revealed that serum IL-6 could be considered to be a predictor of survival up to 5 years for hepatocellular carcinoma patients (log-rank test, P < 0.05). We observed that the serum IL-6 concentration was inversely correlated with miR-26a expression in cancerous tissues (Pearson correlation test, r = -0.651, P < 0.01). Furthermore, by in vitro experiments with HepG2 cells, we showed that IL-6 stimulation can lead to miR-26a suppression via c-Myc activation, whereas in normal hepatocyte LO2 cells incubation with IL-6 had no significant effect on miR-26a expression. Taken together, these results indicate that miR-26a reduction in hepatocellular carcinoma might be due to IL-6 upregulation.
first_indexed 2024-12-20T17:55:20Z
format Article
id doaj.art-d6dc8991287144d5a9c8d1cdc2437a3f
institution Directory Open Access Journal
issn 0100-879X
1414-431X
language English
last_indexed 2024-12-20T17:55:20Z
publishDate 2013-01-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-d6dc8991287144d5a9c8d1cdc2437a3f2022-12-21T19:30:45ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2013-01-014613238Yafei ZhangBicheng ZhangAnran ZhangXiaohua LiJian LiuJie ZhaoYong ZhaoJianfei GaoDianchun FangZhiguo RaoA recent study showed that miR-26a is downregulated in hepatocellular carcinoma tissues and that this downregulation is an independent predictor of survival. Interestingly, the same study also reported that miR-26a downregulation causes a concomitant elevation of IL-6 expression. Because miR-26a expression was found to be transcriptionally downregulated by oncogene c-Myc in various cancers, and the expression of c-Myc was increased by IL-6 stimulation, we hypothesized that IL-6 contributes to reduction of miR-26a in hepatocellular carcinoma. Serum IL-6 was measured by ELISA and miR-26a was detected by qRT-PCR. The data of 30 patients with hepatocellular carcinoma who had undergone surgical tumor resection revealed that serum IL-6 could be considered to be a predictor of survival up to 5 years for hepatocellular carcinoma patients (log-rank test, P < 0.05). We observed that the serum IL-6 concentration was inversely correlated with miR-26a expression in cancerous tissues (Pearson correlation test, r = -0.651, P < 0.01). Furthermore, by in vitro experiments with HepG2 cells, we showed that IL-6 stimulation can lead to miR-26a suppression via c-Myc activation, whereas in normal hepatocyte LO2 cells incubation with IL-6 had no significant effect on miR-26a expression. Taken together, these results indicate that miR-26a reduction in hepatocellular carcinoma might be due to IL-6 upregulation.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000100032MiR-26aIL-6c-MycHepatocellular carcinomaCarcinoma prognosis
spellingShingle Yafei Zhang
Bicheng Zhang
Anran Zhang
Xiaohua Li
Jian Liu
Jie Zhao
Yong Zhao
Jianfei Gao
Dianchun Fang
Zhiguo Rao
Brazilian Journal of Medical and Biological Research
MiR-26a
IL-6
c-Myc
Hepatocellular carcinoma
Carcinoma prognosis
topic MiR-26a
IL-6
c-Myc
Hepatocellular carcinoma
Carcinoma prognosis
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000100032